Skip to main content
Equibles

Kestra Advisory Services, LLC

Position in EXEL — Exelixis, Inc.

CIK 1830819 AUSTIN, TX
Back to EXEL Full portfolio

Position in EXEL

as of Jun 30, 2026 · filed Jul 28, 2026
Position Value
$845,150
+$117,436 QoQ
Shares Held
15,533
-8.5% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
24 quarters on record

Common Shares in EXEL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Kestra Advisory Services, LLC holds $27,730,196 across 51 Biotechnology names. EXEL ranks #8 (3.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 15,732 $7,814,556
2 REGN
Regeneron Pharmaceuticals, Inc.
 2,893 $1,803,901
3 RPRX
Royalty Pharma plc
 27,331 $1,532,449
4 VKTX
Viking Therapeutics, Inc.
 27,091 $1,056,819
5 IBRX
ImmunityBio, Inc.
 110,630 $968,565
6 CORT
Corcept Therapeutics Inc
 10,914 $948,972
7 CRSP
CRISPR Therapeutics AG
 17,292 $943,105
8 EXEL
Exelixis, Inc.
This page 		15,533 $845,150

All Filings in EXEL

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $845,150 15,533
2026-03-31 $727,714 16,967
2025-12-31 $844,779 19,274
2025-09-30 $706,023 17,095
2025-06-30 $734,328 16,659
2025-03-31 $666,073 18,041
2024-12-31 $628,271 18,867
2024-09-30 $307,948 11,867
2024-06-30 $385,585 17,160
2024-03-31 $388,555 16,374
2023-12-31 $415,146 17,305
2023-09-30 $333,977 15,285
2023-06-30 $484,954 25,377
2023-03-31 $421,701 21,726
2022-12-31 $390,509 24,346
2022-09-30 $387,813 24,733
2022-06-30 $510,881 24,538
2022-03-31 $513,362 22,645
2021-12-31 $363,662 19,894
2021-09-30 $292,958 13,858
2021-06-30 $271,077 14,878
2021-03-31 $322,878 14,293
2020-12-31 $379,724 18,920
2020-09-30 $350,221 14,324